XML 33 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Equity Incentive Plans (Tables)
3 Months Ended
Mar. 31, 2022
Equity Incentive Plans  
Assumptions used in the black-Scholes model

There were no grants of stock options during the three months ended March 31, 2022. The assumptions used in the Black-Scholes model during the three months ended March 31, 2021 are presented below:

March 31, 2021

Risk-free interest rate

0.93% - 1.29%

Expected volatility

93.37%

Expected term (in years)

5.50 - 7.00

Expected dividend yield

0%

Allocation of Stock-Based Compensation Expenses

The tables below summarize the total stock-based compensation expense included in the Company’s consolidated statements of operations for the periods presented:

Three Months Ended March 31, 

    

2022

    

2021

    

Research and development

$

303,000

$

353,000

General and administrative

 

190,000

 

489,000

Total stock-based compensation

$

493,000

$

842,000

Summary of Stock Option Activity

Stock option transactions during the three months ended March 31, 2022 are presented below:

Options Outstanding

Weighted

Average

Weighted

Remaining

Average

Contractual

Aggregate

Exercise

Term

Intrinsic

    

Shares

    

Price

    

(Years)

    

Value

Outstanding at December 31, 2021

 

2,409,682

$

5.64

 

8.00

Granted

 

 

 

 

Exercised

Forfeited/Cancelled

 

(103,343)

 

9.50

 

 

Outstanding at March 31, 2022

 

2,306,339

$

5.47

 

7.80

$

2,598,000

Vested and expected to vest at March 31, 2022

 

2,306,339

$

5.47

 

7.80

$

2,598,000

Exercisable at March 31, 2022

 

952,421

$

7.70

 

7.08

$

1,173,000

Schedule of restricted stock awards

Restricted stock awards and restricted stock units during the three months ended March 31, 2022 are presented below:

Weighted Avg

Grant Date

    

Shares

    

Fair Value

Outstanding at December 31, 2021

154,018

$

27.49

Granted

Forfeited/Cancelled

(246)

 

35.22

Vested and Issued as Common Stock

Outstanding at March 31, 2022

153,772

$

27.48

Shares Reserved for Future Issuance

As of March 31, 2022, the Company had reserved shares of its common stock for future issuance as follows:

    

Shares Reserved

Stock options outstanding

 

2,306,339

Unvested restricted stock units

30,000

Employee stock purchase plan

 

9,748

Available for future grants under the 2016 Plan

 

1,667,037

Warrants outstanding

 

21,147,219

Total shares reserved

 

25,160,343